Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Е. В. Артамонова | Researchclopedia

Back to researchers

Е. В. Артамонова

Pirogov Russian National Research Medical University ORCID

187

Works

286

Citations

6

h-index

4

i10-index

Research Topics

Advanced Breast Cancer Therapies HER2/EGFR in Cancer Research Cancer Treatment and Pharmacology

Affiliations

Bakulev Scientific Center for Cardiovascular Surgery Russian Academy of Medical Sciences2021–2023

Pirogov Russian National Research Medical University2019–2025

Russian Cancer Research Center NN Blokhin1996–2025

National Medical and Surgical Center named after N.I. Pirogov2025–2025

Moscow Regional Scientific Research Clinical Institute. MF Vladimirsky2023–2023

Top Works

Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

Yen‐Shen Lu,Eznal Izwadi Bin Mohd Mahidin,et al.

202468 citations

Breast Cancer Treatment Studies

Gastric Cancer Management and Outcomes

Adjuvant Fermented Wheat Germ Extract (Avemar <sup>™</sup> ) Nutraceutical Improves Survival of High-Risk Skin Melanoma Patients: A Randomized, Pilot, Phase II Clinical Study with a 7-Year Follow-Up

Lev Demidov,Ljudmila V. Manziuk,et al.

200847 citations

The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib

Н. В. Мазурина,Е. В. Артамонова,et al.

202111 citations

Microsatellite instability (MSI) in patients with gastric cancer (GC) and correlation with PD-L1 expression.

H. Sun,С. Н. Неред,et al.

202410 citations

Russian consensus on prevention, diagnosis and treatment of gastric cancer

I. E. Khatkov,Sayar Abdulkhakov,et al.

20236 citations

402P First-line ribociclib (RIB) + endocrine therapy (ET) vs combination chemotherapy (combo CT) in aggressive HR+/HER2− advanced breast cancer (ABC): A subgroup analysis of patients (pts) with or without visceral crisis from the phase II RIGHT choice study

Hamdy A. Azim,Nagi S. El Saghir,et al.

20236 citations

Практические рекомендации по лекарственному лечению немелкоклеточного рака легкого

К. К. Лактионов,Е. В. Артамонова,et al.

20215 citations

Final results of a phase II trial of prolgolimab with platinum-based therapy and bevacizumab in patients with advanced cervical cancer.

Sergey Fogt,Timur Andabekov,et al.

20235 citations

A Phase 2 Open-Label Study of Belzutifan (a HIF-2[alpha] Inhibitor) Monotherapy in Patients with Advanced/Metastatic Pheochromocytoma/Paraganglioma or Pancreatic Neuroendocrine Tumors

Camilo Jiménez,Julien Hadoux,et al.

20235 citations